Ord Minnett unveils new recruits
The wealth management group has announced a number of new appointments to broaden its investment research capabilities.
A
A
Ashley Cox will join Ord Minnett’s institutional equities sales team. Mr Cox spent the last 10 years as a director for equities at Deutsche and brings more than 20 years’ experience across equities, derivatives and fixed income to the role. He has also held roles at Corus Capital, Lehman Brothers, NAB, and Merrill Lynch.
Michael Gerges will join Ord Minnett’s Sydney institutional research team as senior research analyst for healthcare. Mr Gerges joins from Blue Ocean Equities, where he covered the healthcare sector across pharmacy, pharmaceuticals, IVF clinics and diagnostic imaging.
Malcolm Wood was appointed to the private client research team and had over 30 years’ experience as an investment strategist, portfolio manager and analyst in Australia and internationally.
Michael Gerges had been appointed senior research analyst (healthcare) and joined the Sydney institutional research team from Blue Ocean Equities where he covered the healthcare sector including pharmacy, pharmaceuticals, IVF clinics and diagnostic imaging among other sub-sectors in health.
Gerges was a pharmacist having operated a network of stores around the Hunter region.
The three research analysts appointed from E. L. & C. Baillieu were James Casey and Nic Burgess (both appointed senior research analysts), and Luke Macnab who was appointed as a research analyst.
Ord Minnett
22 January 2021 – Ord Minnett (Ords), a leading Australian wealth management group, incorporating full-service stockbroking, financial planning, funds management and portfolio services, is pleased to announce the appointment of several key appointments to the Institutional Equities Sales & Research and Private Client Research teams.
Key Appointments
Ord Minnett welcomes the following key appointments:
· Michael Gerges as Senior Research Analyst (Healthcare) who joined the Sydney Institutional Research team on 11 January from Blue Ocean Equities where he covered the healthcare sector including pharmacy, pharmaceuticals, IVF clinics and diagnostic imaging among other sub-sectors in health. Michael was a pharmacist having operated a network of stores around the Hunter region.